These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1232 related items for PubMed ID: 9458021

  • 1. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Transplantation; 1998 Jan 27; 65(2):235-41. PubMed ID: 9458021
    [Abstract] [Full Text] [Related]

  • 2. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: three-year follow-up. The Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Transplantation; 2001 Apr 27; 71(8):1091-7. PubMed ID: 11374408
    [Abstract] [Full Text] [Related]

  • 3. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
    Transplantation; 1996 Apr 15; 61(7):1029-37. PubMed ID: 8623181
    [Abstract] [Full Text] [Related]

  • 4. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group.
    Sollinger HW.
    Transplantation; 1995 Aug 15; 60(3):225-32. PubMed ID: 7645033
    [Abstract] [Full Text] [Related]

  • 5. Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection. The Mycophenolate Mofetil Renal Refractory Rejection Study Group.
    Transplantation; 1996 Mar 15; 61(5):722-9. PubMed ID: 8607174
    [Abstract] [Full Text] [Related]

  • 6. A randomized double-blind comparative study of mycophenolate mofetil and azathioprine in combination with cyclosporine and corticosteroids in primary liver transplant recipients.
    Wiesner R, Rabkin J, Klintmalm G, McDiarmid S, Langnas A, Punch J, McMaster P, Kalayoglu M, Levy G, Freeman R, Bismuth H, Neuhaus P, Mamelok R, Wang W.
    Liver Transpl; 2001 May 15; 7(5):442-50. PubMed ID: 11349266
    [Abstract] [Full Text] [Related]

  • 7. Analysis of a single-center experience with mycophenolate mofetil based immunosuppression in renal transplantation.
    Triemer HL, Pearson TC, Odom KL, Larsen CP.
    Clin Transplant; 2000 Aug 15; 14(4 Pt 2):413-20. PubMed ID: 10946781
    [Abstract] [Full Text] [Related]

  • 8. Randomized, prospective trial of mycophenolate mofetil versus azathioprine for prevention of acute renal allograft rejection after simultaneous kidney-pancreas transplantation.
    Merion RM, Henry ML, Melzer JS, Sollinger HW, Sutherland DE, Taylor RJ.
    Transplantation; 2000 Jul 15; 70(1):105-11. PubMed ID: 10919583
    [Abstract] [Full Text] [Related]

  • 9. Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups.
    Halloran P, Mathew T, Tomlanovich S, Groth C, Hooftman L, Barker C.
    Transplantation; 1997 Jan 15; 63(1):39-47. PubMed ID: 9000658
    [Abstract] [Full Text] [Related]

  • 10. Rescue therapy with mycophenolate mofetil. The Mycophenolate Mofetil Renal Refractory Rejection Study Group.
    Clin Transplant; 1996 Feb 15; 10(1 Pt 2):131-5. PubMed ID: 8680050
    [Abstract] [Full Text] [Related]

  • 11. Mycophenolate mofetil for prevention of liver allograft rejection: initial results of a controlled clinical trial.
    Sterneck M, Fischer L, Gahlemann C, Gundlach M, Rogiers X, Broelsch C.
    Ann Transplant; 2000 Feb 15; 5(1):43-6. PubMed ID: 10850611
    [Abstract] [Full Text] [Related]

  • 12. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. European Mycophenolate Mofetil Cooperative Study Group.
    Lancet; 1995 May 27; 345(8961):1321-5. PubMed ID: 7752752
    [Abstract] [Full Text] [Related]

  • 13. Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients.
    Wagner M, Earley AK, Webster AC, Schmid CH, Balk EM, Uhlig K.
    Cochrane Database Syst Rev; 2015 Dec 03; 2015(12):CD007746. PubMed ID: 26633102
    [Abstract] [Full Text] [Related]

  • 14. A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation.
    Vacher-Coponat H, Moal V, Indreies M, Purgus R, Loundou A, Burtey S, Brunet P, Moussi-Frances J, Daniel L, Dussol B, Berland Y.
    Transplantation; 2012 Feb 27; 93(4):437-43. PubMed ID: 22228415
    [Abstract] [Full Text] [Related]

  • 15. Results of a randomized, prospective, multicenter trial of mycophenolate mofetil versus azathioprine in the prevention of acute lung allograft rejection.
    Palmer SM, Baz MA, Sanders L, Miralles AP, Lawrence CM, Rea JB, Zander DS, Edwards LJ, Staples ED, Tapson VF, Davis RD.
    Transplantation; 2001 Jun 27; 71(12):1772-6. PubMed ID: 11455257
    [Abstract] [Full Text] [Related]

  • 16. A study comparing mycophenolate mofetil to azathioprine in simultaneous pancreas-kidney transplantation.
    Odorico JS, Pirsch JD, Knechtle SJ, D'Alessandro AM, Sollinger HW.
    Transplantation; 1998 Dec 27; 66(12):1751-9. PubMed ID: 9884272
    [Abstract] [Full Text] [Related]

  • 17. Mycophenolate mofetil in renal transplantation: 3-year results from the placebo-controlled trial. European Mycophenolate Mofetil Cooperative Study Group.
    Transplantation; 1999 Aug 15; 68(3):391-6. PubMed ID: 10459543
    [Abstract] [Full Text] [Related]

  • 18. Conversion from mycophenolate mofetil to azathioprine in renal allograft [corrected] patients within the first month posttransplantation.
    Zhu B, Liu Z, Wu C, Wang P, Wang X, Xu H.
    Transplant Proc; 2008 Sep 15; 40(7):2258-61. PubMed ID: 18790207
    [Abstract] [Full Text] [Related]

  • 19. Comparison of azathioprine and mycophenolate mofetil for the prevention of acute rejection in recipients of pancreas transplantation.
    Oh JM, Wiland AM, Klassen DK, Weidle PJ, Bartlett ST.
    J Clin Pharmacol; 2001 Aug 15; 41(8):861-9. PubMed ID: 11504274
    [Abstract] [Full Text] [Related]

  • 20. Reduced kidney transplant rejection rate and pharmacoeconomic advantage of mycophenolate mofetil.
    Wüthrich RP, Weinreich T, Ambühl PM, Schwarzkopf AK, Candinas D, Binswanger U.
    Nephrol Dial Transplant; 1999 Feb 15; 14(2):394-9. PubMed ID: 10069195
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 62.